A comprehensive 2026 guide to UK online casinos with a 400% bonus. Understand wagering, find the best offers, and see if a 4x match is actually worth it. Read our full guide to 400% casino bonuses
JBM Healthcare Announces FY2026 Annual Results
– Delivers Resilient Performance with Revenue Growth of 6.7% – Profit Attributable to Shareholders Increases 1.9% despite Increased Strategic Investment – Flagship Brands Continue to Drive Growth and Market Leadership…
JBM Healthcare Delivers Strong FY2025 Annual Results, Net Profit Surged 51.2% to HK$197.3 Million
– Flagship Brands and Channel Optimisation Capture Demand in Challenging Climate JBM (Healthcare) Limited (JBM Healthcare or the Company; HKG: 2161, together with its subsidiaries, the Group), a leading branded…
JBM Healthcare Completes Acquisition of 90% Interest in Tin Hee Tong
– Strategic Acquisition Expands Market-Leading Proprietary Chinese Medicines Portfolio JBM (Healthcare) Limited (JBM Healthcare; HKG: 2161, together with its subsidiaries, the Group), a leading branded healthcare products marketer and distributor…
JBM Healthcare Announces FY2025 Interim Results
– Net Profit Surges 53.4% to HK$95.9 Million – Interim Dividend of HK5.50 cents per share, up by 59.4% year-on-year – Flagship Proprietary Brands Ho Chai Kung and Po Chai…
JBM Healthcare Issues Positive Profit Alert
– Anticipates Not Less Than 50% Rise in Consolidated Profit Attributable to Shareholders JBM (Healthcare) Limited (JBM Healthcare or the Company; Stock Code: 2161, together with its subsidiaries, the Group),…
JBM Healthcare Announces FY2024 Annual Results
– Adjusted Profit* Surges 149.5% to HK$130.5 Million – Flagship Brands Spearhead Growth with Effective Strategies – Recommends Final Dividend of HK4.05 Cents Per Share KEY HIGHLIGHTS Year-on-year revenue increased…
JBM Healthcare Announces FY2023 Annual Results
Net Profit Surges 132% to HK$57.1 Million Proprietary Chinese Medicines Witness Robust Growth of 54.5% Recommends Final Dividend of HK2.5 Cents Per Share JBM (Healthcare) Limited (JBM Healthcare or the…
JBM Healthcare Announces FY2023 Interim Results
Net Profit Increases 116% to HK$21.6 Million Declares Interim Dividend of HK0.5 Cent Per Share Resilient Performance as Growth Momentum is Set to Continue JBM (Healthcare) Limited (JBM Healthcare or…
JBM Healthcare Announces FY2021 Annual Results
Adjusted Net Profit* Increases by 13.3% to HK$54.6 Million JBM (Healthcare) Limited (JBM Healthcare or the Group; Stock Code: 2161), a leading branded healthcare products marketer and distributor in Hong…